IDEAYA Biosciences, Inc.

Healthcare · Biotechnology · United States

Last price 32.89 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 3.17B

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

IDEAYA Biosciences, Inc., a precision medicine oncology company, develops targeted therapeutics for patient populations selected using molecular diagnostics in the United States. The company offers Darovasertib, an oral, potent, and selective protein kinase, C (PKC) inhibitor for the treatment of uveal melanoma, ocular cancer, and is being evaluated in multiple clinical trials as monotherapy and in combination with crizotinib for metastatic, neoadjuvant, and adjuvant settings. The company also offers IDE849, a DLL3 antibody drug conjugate inhib...